By Mary Guzman
Apple's July 10, 2026 lawsuit against OpenAI, filed in the Northern District of California just five weeks after OpenAI's confidential Form S‑1 targeted a trillion‑dollar valuation, presents a governance case study with implications far beyond Silicon Valley. In Apple Inc. v. Liu, No. 5:26‑cv‑07078, Apple alleges that OpenAI Group PBC, OpenAI Foundation, io Products LLC, former Apple vice president Tang Yew Tan, and former Apple engineer Chang Liu engaged in a coordinated effort to obtain confidential Apple hardware designs, supply‑chain intelligence, and unreleased product specifications. Apple claims the misappropriation reached every level of OpenAI's hardware organization and seeks preliminary and permanent injunctions, compensatory damages, a reasonable royalty in the alternative, exemplary damages for willful misappropriation, and attorneys' fees*. OpenAI denies all allegations and points to Apple's allegedly lax exit procedures as the key negating factor.
From a governance perspective, the case highlights a recurring pattern: trade‑secret disputes that appear straightforward to the public often reveal deeper structural weaknesses inside the victim organization. The industry has seen versions of this before—emails encouraging departing employees to "bring what you know," or the more extreme mole scenario, as in Deel v. Rippling. These are not just operational failures; they are governance failures that should alarm any board member or investor expecting a clean exit or a stable competitive position.
The risk is accelerating. More than 1,500 federal trade‑secret cases were filed in 2025 – the highest ever – and still only a fraction of the true number. AI proliferation, high employee mobility, and limits on non‑competes ensure that trade‑secret litigation will continue to rise. Meanwhile, companies increasingly rely on trade‑secret protection (surpassing the long-favored patent-or-die approach) recognizing that patents disclose the playbook to competitors and nation‑state adversaries. In a world where competitive advantage is often driven by a process rather than the output it creates, trade secrets are often the most valuable and strategic IP ******* et.
But the governance question is always the same: Did the company actually have protectable trade secrets? That requires: a) legal ownership of the innovation, b) demonstrable uniqueness that creates value, and c) "reasonable measures" to protect it.
#confidential #case
Apple's July 10, 2026 lawsuit against OpenAI, filed in the Northern District of California just five weeks after OpenAI's confidential Form S‑1 targeted a trillion‑dollar valuation, presents a governance case study with implications far beyond Silicon Valley. In Apple Inc. v. Liu, No. 5:26‑cv‑07078, Apple alleges that OpenAI Group PBC, OpenAI Foundation, io Products LLC, former Apple vice president Tang Yew Tan, and former Apple engineer Chang Liu engaged in a coordinated effort to obtain confidential Apple hardware designs, supply‑chain intelligence, and unreleased product specifications. Apple claims the misappropriation reached every level of OpenAI's hardware organization and seeks preliminary and permanent injunctions, compensatory damages, a reasonable royalty in the alternative, exemplary damages for willful misappropriation, and attorneys' fees*. OpenAI denies all allegations and points to Apple's allegedly lax exit procedures as the key negating factor.
From a governance perspective, the case highlights a recurring pattern: trade‑secret disputes that appear straightforward to the public often reveal deeper structural weaknesses inside the victim organization. The industry has seen versions of this before—emails encouraging departing employees to "bring what you know," or the more extreme mole scenario, as in Deel v. Rippling. These are not just operational failures; they are governance failures that should alarm any board member or investor expecting a clean exit or a stable competitive position.
The risk is accelerating. More than 1,500 federal trade‑secret cases were filed in 2025 – the highest ever – and still only a fraction of the true number. AI proliferation, high employee mobility, and limits on non‑competes ensure that trade‑secret litigation will continue to rise. Meanwhile, companies increasingly rely on trade‑secret protection (surpassing the long-favored patent-or-die approach) recognizing that patents disclose the playbook to competitors and nation‑state adversaries. In a world where competitive advantage is often driven by a process rather than the output it creates, trade secrets are often the most valuable and strategic IP ******* et.
But the governance question is always the same: Did the company actually have protectable trade secrets? That requires: a) legal ownership of the innovation, b) demonstrable uniqueness that creates value, and c) "reasonable measures" to protect it.
#confidential #case
1 day ago
